Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan MacGregor

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Immunity|February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanomaAndrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Neurology|April 19, 2015
The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasiaA Simon Harvey, Simone A Mandelstam, Wirginia J Maixner, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2011
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™Theo Nicholaou, Weisan Chen, Ian D Davis, et al.
Journal of Neuro-Oncology|March 21, 2016
Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutationAndrew J Dodgshun, Nadine SantaCruz, Jaeho Hwang, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIAWei Shern Lee, Sarah E M Stephenson, Katherine B Howell, et al.
Immunotherapy|February 11, 2017
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantIan D Davis, Juliet Quirk, Leone Morris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patientsIan D Davis, Qiyuan Chen, Leone Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigenAndrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptakeAndrew M Scott, Fook-Thean Lee, Robert Jones, et al.
Neurology|May 5, 2021
One-Stage, Limited-Resection Epilepsy Surgery for Bottom-of-Sulcus DysplasiaEmma Macdonald-Laurs, Wirginia J Maixner, Catherine A Bailey, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Immunity|February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanomaAndrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Neurology|April 19, 2015
The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasiaA Simon Harvey, Simone A Mandelstam, Wirginia J Maixner, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2011
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™Theo Nicholaou, Weisan Chen, Ian D Davis, et al.
Journal of Neuro-Oncology|March 21, 2016
Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutationAndrew J Dodgshun, Nadine SantaCruz, Jaeho Hwang, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIAWei Shern Lee, Sarah E M Stephenson, Katherine B Howell, et al.
Immunotherapy|February 11, 2017
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantIan D Davis, Juliet Quirk, Leone Morris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patientsIan D Davis, Qiyuan Chen, Leone Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigenAndrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptakeAndrew M Scott, Fook-Thean Lee, Robert Jones, et al.
Neurology|May 5, 2021
One-Stage, Limited-Resection Epilepsy Surgery for Bottom-of-Sulcus DysplasiaEmma Macdonald-Laurs, Wirginia J Maixner, Catherine A Bailey, et al.
Pageof 6